Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Interleukin (IL)-25 suppresses IL-22-induced osteoclastogenesis in rheumatoid arthritis via STAT3 and p38 MAPK/IκBα pathway

Fig. 1

IL-22 and IL-25 expression in serum, synovial fluid, and synovial tissue from patients with rheumatoid arthritis (RA). a Concentrations of IL-25 were determined in the synovial fluid and serum of RA and OA, and healthy control subjects. b Correlations between the IL-22 and IL-25 concentrations were assessed in the synovial fluid and serum of patients with RA. c Expression of IL-25 was detected in the synovium of patients with RA and OA patients using immunohistochemical staining, with hematoxylin and eosin (H&E) counterstaining. Original magnification × 400. ***P < 0.001

Back to article page
\